Lenvatinib-induced pemphigus erythematosus in hepatocellular carcinoma: a unique case report

Lenvatinib-induced pemphigus erythematosus in hepatocellular carcinoma: a unique case report

Adjuvant lenvatinib in combination with transarterial chemoembolization (TACE) has demonstrated prolonged disease-free survival in hepatocellular carcinoma patients at high risk of recurrence post-resection. Here, we present the case of a 68-year-old woman who developed serious side effects includin...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoqing Li, Suhua Ma, Qing She, Zirong Liu, Yanan Liu, Yanjing Kuang, Xiaozhun Huang, Zhengyin Zhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
lenvatinib
hepatocellular carcinoma
pemphigus
adverse drug reaction
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1505596/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items